AbbVie and Allergan: not an A* Deal (CNBC)
With the announcement of the latest pharma mega-merger, AbbVie’s move to buy Allergan for $63bn, John Rountree, was invited on CNBC to discuss the deal and the continuing trend of pharma mega-mergers. John questions where the value is in the deal, with Allergan’s shareholders being the only likely benefactors. He highlights the defensive nature of […]
European entry – How Biotechs Can Succeed in Europe
The European pharmaceutical market is the second largest globally after the US. In 2017 the markets accounted for 22.2% and 48.1% of world pharmaceutical sales, respectively, and for sales of new medicines launched between 2012-2017 the trend continues – 64.1% for US compared to 18.1% for the top 5 markets in Europe (France, Germany, Italy, […]